Overview

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis.

Status:
NOT_YET_RECRUITING

Trial end date:
2031-12-30

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the safety, tolerability, and efficacy of BBM-A101 to treat participants with knee osteoarthritis.

Phase:

PHASE1

Details

Lead Sponsor:

Belief BioMed (Beijing) Co., Ltd